PBE ETF: Invesco Biotechnology & Genome ETF - Price, Holdings & Analysis
Invesco Biotechnology & Genome ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Invesco Biotechnology & Genome ETF
What is the current price of PBE?
The latest PBE price is $78.86. The 52-week range is $54.52–$85.73. PBE has returned 28.1% over the past 52 weeks.
What is the expense ratio for PBE?
PBE's annual expense ratio is 0.58%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does PBE pay dividends?
Yes, PBE pays a 1.03% dividend yield. The last ex-dividend date was 2026-06-27. View full dividend history in the Dividends section.
What are the top holdings of PBE?
PBE's largest holdings are United Therapeutics Corporation (6.3%), Gilead Sciences, Inc (6.0%), Amgen Inc (5.8%) (combined weight: 18.1%). The fund holds 33 total positions. View the complete portfolio breakdown in the Holdings section.
How does PBE compare to similar ETFs?
Compare PBE (0.58% expense ratio, $248M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.